Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - KEMPHARM, INC | d122114dex51.htm |
| S-1MEF - S-1MEF - KEMPHARM, INC | d122114ds1mef.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-1 of KemPharm, Inc. filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, of our report dated February 28, 2020, except for the Reverse Stock Split paragraph of Note A as to which the date is December 27, 2020, relating to the financial statements of KemPharm, Inc., appearing in the Prospectus, which is a part of the Registration Statement (No. 333-250945) on Form S-1 declared effective on January 7, 2021.
/s/ RSM US LLP
Orlando, Florida
January 7, 2021